Effect of a Low Dose of Dietary Resveratrol on Colon Microbiota, Inflammation and Tissue Damage in a DSS-Induced Colitis Rat Model
- 19 February 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 57 (6) , 2211-2220
Abstract
The naturally occurring polyphenol resveratrol has been acknowledged with health-beneficial properties. Most of the studies dealing with its in vivo effects assay huge doses, not representative from a dietary point of view. Our aim was to ascertain whether resveratrol can exert anti-inflammatory activity in vivo at an attainable dietary dose. Rats were fed with 1 mg of resveratrol/kg/day (a human equivalent dose) for 25 days, and in the last 5 days, 5% dextran sulfate sodium (DSS) was administered to induce colitis. Effects on colon tissue damage, gut microbiota, reactive oxygen species, inflammatory markers and nitric oxide production as well as gene expression profile with microarrays were evaluated. Resveratrol increased lactobacilli and bifidobacteria as well as diminished the increase of enterobacteria upon DSS treatment. Resveratrol significantly protected the colonic mucosa architecture, reduced body weight loss, diminished the induced anemia and reduced systemic inflammation markers, colonic mucosa prostaglandin E2, cycloxygenase-2, prostaglandin E synthase and nitric oxide levels. In addition, the expression of 2,655 genes in distal colon mucosa related to important pathways was varied. These results reinforce the concept of resveratrol as a dietary beneficial compound in intestinal inflammation at doses possibly attainable with resveratrol-enriched nutraceuticals.Keywords
This publication has 39 references indexed in Scilit:
- Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohortBritish Journal of Nutrition, 2008
- Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapyWorld Journal of Gastroenterology, 2008
- Nutraceuticals: Facts and fictionPhytochemistry, 2007
- Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitisInternational Immunopharmacology, 2007
- A review of the content of the putative chemopreventive phytoalexin resveratrol in red wineFood Chemistry, 2007
- Effects of Resveratrol in Inflammatory ArthritisInflammation, 2006
- Bifidobacterium infantisstrains with and without a combination of Oligofructose and Inulin (OFI) attenuate inflammation in DSS-induced colitis in ratsBMC Gastroenterology, 2006
- Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitisInflammation Research, 2005
- Postharvest Stilbene-Enrichment of Red and White Table Grape Varieties Using UV-C Irradiation PulsesJournal of Agricultural and Food Chemistry, 2002
- Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws ratsClinical and Experimental Immunology, 2000